Here, we compared the status of ERα, PR, and HER2 in primary tumors and in paired excised brain metastases in a relatively large series of breast cancer patients, assessed the impact of factors potentially influencing receptor conversion, and evaluated association of particular phenotypic changes with survival. This evidence concerns the gene PGR and breast cancer.